Biomedical diagnostics have been radically altered by the introduction of nanomaterials, which have allowed for the development of detection technologies that are very sensitive, quick, and accurate. This chapter explores the ways in which imaging agents, biosensors, and nanoprobes are revolutionizing customized medicine and disease diagnostics. Nanomaterials have special qualities like being highly conductive, able to change the way light bends, and having a very large surface area. These latest instruments use these behaviors to find biomarkers, infections, and molecular changes on a scale that has never been seen before. This integration biosensors with nanomaterials enables very precise early illness detection and real-time point-of-care diagnostics. Nanoprobes designed to find molecules improve targeted imaging and therapy monitoring to help us learn more about diseases developing. There are advancements in contrast, resolution, and the ability to accurately identify cellular abnormalities. This medical imaging has been reimagined with the help of advanced imaging agents like quantum dots and gold nanoparticles. Despite their revolutionary promise, these breakthroughs must overcome obstacles such as scalability, obtaining regulatory clearances, and addressing biocompatibility issues. In order to integrate diagnostics based on nanomaterials into standard healthcare, it is crucial to address these challenges through multidisciplinary research, ethical considerations, and robust clinical validation. In the coming years, nanotechnologies like imaging agents, nanoprobes, and biosensors will performance a bigger part in primary disease finding, personalized therapy, and non-invasive diagnostics. This will eventually have an effect on the coming of personalized medication. This chapter explored the age of healthcare innovations powered by nanotechnology.